Centene Corporation (CNC) Institutional Ownership & Insider Trading

1,002 institutions reported holding Centene Corporation shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings. 5 insider trades on Form 4 since 2025-10-01.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

CNCCentene CorporationFollow CNC — free

Healthcare Plans · Healthcare

—

Price chart with a free account

Market cap: 34.7B
P/E TTM: —
Dividend yield: —
52-week: —
Next earnings: 27 Oct, in 3 days

Institutions · all 13F filers

quarter to 30 Jun 2026 · filers in both quarters

1,002 institutions held 98.7% of the shares. Across filers that reported both quarters, shares held changed +1.6%.

Largest moves, shares (millions)

Institutional flow by quarter

net shares added or trimmed, millions · filers in both quarters

Quarter	Holders	Shares held, M	Change	Increased	New	Decreased	Closed
Jun 26	1,002	487	+1.6%	318	183	321	54
Mar 26	855	472	+2.7%	275	65	324	110
Dec 25	892	475	+1.3%	312	118	259	82
Sep 25	829	460	+1.7%	313	128	240	151
Jun 25	849	478	-1.7%	309	72	262	102
Mar 25	875	456	+0.7%	295	85	296	71
Dec 24	847	480	-4.9%	251	68	327	114
Sep 24	857	470	-7.3%	261	62	310	73

Centene Corporation — questions

Who owns Centene Corporation stock?: 1,002 institutions reported Centene Corporation shares in 13F filings for the quarter ended 2026-06-30. The largest: BlackRock, Inc. (8.4%), VANGUARD CAPITAL MANAGEMENT LLC (6.4%), AQR CAPITAL MANAGEMENT LLC (5.8%).
Are Centene Corporation insiders buying or selling?: 5 insider trades on Form 4 since 2025-10-01; the full list, with dates, people and plan status, is on this page.

Every figure on this page comes from Centene Corporation's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.

Important information. Figures on this page are taken from filings submitted to the U.S. Securities and Exchange Commission (SEC) and processed automatically by EquiReason. They may contain errors, omissions or delays, and EquiReason makes no representation or warranty as to their accuracy, completeness or timeliness. Always verify figures against the original filing on SEC EDGAR before relying on them.

This page is provided for general information and educational purposes only. It does not constitute investment, financial, legal or tax advice, and it is not a recommendation or an offer to buy, sell or hold any security. It does not take into account your objectives, financial situation or needs. Past performance does not guarantee future results; any reliance on this information is at your own risk. See our Disclaimer and Risk Disclosure.